US 9868698
(2S,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-4-(ethoxyoxalylamino)-2-hydroxymethyl-2-methylpentanoic acid
granted A61KA61K31/216A61K45/06
Quick answer
US patent 9868698 ((2S,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-4-(ethoxyoxalylamino)-2-hydroxymethyl-2-methylpentanoic acid) held by Theravance Biopharma R&D IP, LLC expires Mon Jan 11 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance Biopharma R&D IP, LLC
- Grant date
- Tue Jan 16 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 11 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 2
- CPC classes
- A61K, A61K31/216, A61K45/06, A61K9/0019, A61K9/0075